Biotech, Cannabis, Food & Drug, & Pharma Law Updates

HB Ad Slot
HB Mobile Ad Slot

In today’s hyper-aware environment, concerns about food and drug safety are paramount for both companies and consumers.  The Food and Drug Administration (FDA) and the US Department of Agriculture (USDA) regulates the areas of biotech, food, and drug law. Additionally, laws including the 21st Century Cures Act, and cGMP (Current Good Manufacturing Processes), regulate industry standards/norms in food, cosmetics, and other industry-sectors. Visitors to the National Law Review will find the latest analysis of news, legislation, and upcoming cases/litigation as it relates to this area of law.

With researchers searching for new energy solutions and other developments in biotech, visitors to the NLR will have the opportunity to read content surrounding biosimilars, natural fuel production, medical devices, biotechnology, nanotechnology and materials, and the pharmaceuticals industry. Additionally, content relating to food and drug laws, limits on chemical use in cosmetic products, and other general health/safety topics are covered by the National Law Review and are updated regularly. Additionally, food safety and imports to the United States are also discussed as they become relevant. 

In addition to general health, science, and food/drug, the industry is also closely related to many of the issues related to intellectual property law. New applications for patents, intellectual property, licensing laws, and other areas which are governed by the PTAB court, often crossover into the industry.

New developments in legislation, including the legalization of recreational marijuana has created a new area ripe for legal analysis.  Regulations on how recreational marijuana can be advertised and marketed, distributed and the kind of insurance coverage necessary for dispensaries.  Additionally, employer drug-testing and marijuana statutes have been a hot area of litigation covered by the National Law Review.  

General practices in marketing standards, compliance of federal and state laws/legislation, licensing collaborations, and news related to bringing new products to the market, in the US and abroad, are among the areas visitors to NLR will read about daily. Drug pricing, changes in production standards, regulatory compliance, food safety and handling, drug laws (legalization of marijuana, both recreational and medicinal in the workplace), and labeling and nutritional requirements, are among the many topics covered by the National Law Review daily.

Visitors will always find the latest, up-to-date, most comprehensive coverage on the site. And, news and stories which affect the US, companies which are regulated in the industry, and multinational/international companies, are detailed regularly for NLR readers.

National Law Review Cannabis TwitterFor hourly updates on the latest news about biotech, food & drug, and cannabis laws, regulations, and legislation, be sure to follow our Cannabis X (formerly Twitter) feed, and sign up for complimentary e-news bulletins.

Recent Biotech, Cannabis, Food & Drug, & Pharma Administration News

Title
Publication Date Organization
Oct
5
2021
California Jury Awards Millions to Cannabis Company in Antitrust Case Sheppard, Mullin, Richter & Hampton LLP
Oct
5
2021
“Butter” Luck Next Time: Court Finds California Cannot Preclude Vegan Dairy from Using “Vegan Butter” Labeling Proskauer Rose LLP
Oct
5
2021
FDA Approves New Blue Color Additive Keller and Heckman LLP
Oct
5
2021
Federal Court Upholds GRAS Rule Keller and Heckman LLP
Oct
4
2021
New House Report on Heavy Metals in Baby Food Keller and Heckman LLP
Oct
1
2021
FDA Issues Draft Guidance on Use of Real-World Information to Support FDA Regulatory Decision-Making for Drugs, Biologics Greenberg Traurig, LLP
Sep
30
2021
Update on Medical Marijuana in Mississippi: Legislature Leaders Agree on Draft Bill & Call For Special Session Bradley Arant Boult Cummings LLP
Sep
30
2021
Biometric Information Privacy Programs Robinson & Cole LLP
Sep
30
2021
UK Clears Path for Gene Editing Keller and Heckman LLP
Sep
30
2021
California OEHHA Proposes New Safe Harbor Warnings for Acrylamide in Foods Foley & Lardner LLP
Sep
29
2021
DEA Issues Public Safety Alert Concerning Fake Prescription Pills Containing Fentanyl and Methamphetamine Jackson Lewis P.C.
Sep
29
2021
Supreme Court Asked to Review Prop 12 Challenge Keller and Heckman LLP
Sep
29
2021
Impact of NYC’s New Delivery Service Data Sharing Requirement Sheppard, Mullin, Richter & Hampton LLP
Sep
28
2021
Nota Bene Episode 145: Tuna Sustainability: A Model Bigger than its Niche with ISSF President Susan Jackson [PODCAST] Sheppard, Mullin, Richter & Hampton LLP
Sep
28
2021
U.S. House Passes the SAFE Banking Act as Part of Defense Bill Bradley Arant Boult Cummings LLP
Sep
28
2021
PBM Regulatory Landscape Roundup (Summer 2021): A Flurry of Regulations, Rutledge, and a Crucial 8th Circuit Decision Mintz
Sep
28
2021
OSHA Holds Public Hearing on Proposed Amendments to the Hazard Communication Standard Bergeson & Campbell, P.C.
Sep
28
2021
California Expands PPE Stockpile and Employee Training Requirements to Address Wildfire Smoke Events Jackson Lewis P.C.
Sep
28
2021
FDA Issues Revised Final Guidance On Biosimilar Development And The BPCI Act Bergeson & Campbell, P.C.
Sep
28
2021
California to Allow Hemp and CBD in Food/Supplements – Legal Risks Persist for the Unwary Wilson Elser Moskowitz Edelman & Dicker LLP
Sep
28
2021
Lawsuit Alleges Fat Content Deceptively Labeled Keller and Heckman LLP
Sep
27
2021
Tough Yardage Barnes & Thornburg LLP
Sep
27
2021
Another Vanilla Lawsuit Dismissed Keller and Heckman LLP
Sep
27
2021
Federal Circuit Crystallizes BMS’ Apixaban District Court Win Finnegan
Sep
24
2021
Safer Federal Workforce Task Force Publishes Guidance for Contractor COVID-19 Vaccine Mandate Polsinelli PC
Sep
24
2021
The Battle over BLACK IRISH Liqueur Norris McLaughlin P.A.
Sep
24
2021
HRSA Refers Six Drug Manufacturers to OIG for Possible 340B-Related Civil Penalties Dinsmore & Shohl LLP
Sep
24
2021
Court Upholds Termination of Employee Who Used Prescription Medication That Was Prescribed 5 Years Earlier Jackson Lewis P.C.
 

NLR Logo

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up to receive our free e-Newsbulletins

 

Sign Up for e-NewsBulletins